Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts

SIMPLE SUMMARY: Mucinous adenocarcinoma develops in 10–20% of all colorectal cancer (CRC) cases. This subtype is characterized by its worse clinicopathological features, including but not limited to more advanced stages at the time of tumor diagnosis, it being more frequent in the proximal colon, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Herold, Zoltan, Acs, Miklos, Szasz, Attila Marcell, Olasz, Katalin, Hussong, Jana, Mayr, Max, Dank, Magdolna, Piso, Pompiliu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406628/
https://www.ncbi.nlm.nih.gov/pubmed/36010972
http://dx.doi.org/10.3390/cancers14163978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406628/
https://www.ncbi.nlm.nih.gov/pubmed/36010972
http://dx.doi.org/10.3390/cancers14163978

Ejemplares similares